Showing results (401-410 of 561) with videos related to

Sort By:
Pageof 57
European Heart Journal Open|July 9, 2026
Pathology-validated prevalence and clinical characteristics of coronary medial arterial calcificationYuki Matsumoto, Sho Torii, Kazuki Aihara, et al.
European Heart Journal Open|July 22, 2026
Correction to: Intravascular imaging in peripheral arterial disease: a contemporary literature review
European Heart Journal Open|August 28, 2026
Genotype status and arrhythmic risk in sport participants with hypertrophic cardiomyopathyFrédéric Myon, Mathilde Delatour, Nathalie Behar, et al.
European Heart Journal Open|January 10, 2022
Creating a better journey of care for patients with heart valve diseaseMarta Sitges, Britt Borregaard, Ruggero De Paulis, et al.
European Heart Journal Open|October 18, 2021
Pericoronary and periaortic adipose tissue density are associated with inflammatory disease activity in Takayasu arteritis and atherosclerosisChristopher Wall, Yuan Huang, Elizabeth P V Le, et al.
European Heart Journal Open|January 5, 2023
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patientsP Rossignol, K Duarte, E Bresso, et al.
European Heart Journal Open|January 5, 2023
Effectiveness and feasibility of cardiovascular disease personalized prevention on high polygenic risk score subjects: a randomized controlled pilot studyMargus Viigimaa, Mikk Jürisson, Heti Pisarev, et al.
European Heart Journal Open|August 25, 2025
Echocardiographic risk stratification in light chain and transthyretin amyloidosis: a meta-analysisDavid Koeckerling, Rohin K Reddy, Christian Eichhorn, et al.
European Heart Journal Open|September 5, 2025
Native T1 adds independent value for cardiovascular risk assessment beyond global longitudinal strain in an all-comers real-world clinical patient populationSören J Backhaus, Julia Treiber, Jan Sebastian Wolter, et al.
European Heart Journal Open|February 23, 2023
Clinical significance of the rivaroxaban-dronedarone interaction: insights from physiologically based pharmacokinetic modellingBurkhard Hügl, Marc Horlitz, Kerstin Fischer, et al.
Pageof 57